ArticlePatient preference and adherence2013

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.

Luigi Celio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.